SCHEMBL541120

SCHEMBL541120

CC/C(C#N)=C(\C(=O)O)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8798259 0.73 FFAR3 (0.36) FFAR3
SCHEMBL11051239 0.73 FFAR3 (0.36) FFAR3
SCHEMBL1275717 0.72 ALDH1A1 (0.41)
SCHEMBL25436797 0.71 FFAR3 (0.35) FFAR3
SCHEMBL2580161 0.71 ALDH1A1 (0.35) FFAR3
SCHEMBL525227 0.71 ALDH1A1 (0.35) FFAR3
SCHEMBL4475759 0.71 TP53 (0.31)
SCHEMBL1275701 0.71 TSHR (0.32)
SCHEMBL3516773 0.69 GRIK1 (0.38) FFAR3
SCHEMBL9322240 0.69 ALDH1A1 (0.36) FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153743-B2 Controlled exotherm of cyanoacrylate formulations CLOSURE MEDICAL CORPORATION (US) 2012-04-10 US disclosed
EP-2413943-A1 CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS Ethicon, Inc (US) 2012-02-08 EP disclosed
EP-2307515-A2 CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS Ethicon, Inc. (US) 2011-04-13 EP disclosed
WO-2010114779-A1 CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS ETHICON, INC. (US) 2010-10-07 WO disclosed
US-20100249698-A1 CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS ETHICON, INC. 2010-09-30 US disclosed
US-20100030258-A1 Controlled Exotherm of Cyanoacrylate Formulations ETHICON, INC. 2010-02-04 US disclosed
WO-2010014641-A2 CONTROLLED EXOTHERM OF CYANOACRYLATE FORMULATIONS CLOSURE MEDICAL CORPORATION (US) 2010-02-04 WO disclosed